Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB3 | P13945 | 18/20 | 0.54 |
| ▸ | ADRB1 | P08588 | 17/20 | 0.54 |
| ▸ | ADRB2 | P07550 | 16/20 | 0.54 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | GFER | P55789 | 1/20 | 0.43 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7608477 | 0.89 | ADRB3 (0.59) | ADRB3ADRB1ADRB2GAAGFER | |
| SCHEMBL7611161 | 0.88 | ADRB3 (0.56) | ADRB3ADRB1ADRB2GAAGFER | |
| SCHEMBL7605897 | 0.86 | ADRB3 (0.56) | ADRB3ADRB2GAAGFERAPOBEC3G | |
| SCHEMBL7613217 | 0.84 | ADRB2 (0.45) | ADRB3ADRB1ADRB2 | |
| SCHEMBL7611056 | 0.82 | ADRB3 (0.45) | ADRB3ADRB1ADRB2GAAGFER | |
| SCHEMBL7609817 | 0.82 | ADRB3 (0.61) | ADRB3ADRB1ADRB2 | |
| SCHEMBL7605875 | 0.81 | ADRB1 (0.46) | ADRB3ADRB1ADRB2 | |
| SCHEMBL7610428 | 0.80 | ADRB3 (0.58) | ADRB3ADRB1ADRB2 | |
| SCHEMBL7611605 | 0.78 | ADRB3 (0.56) | ADRB3ADRB2GAAGFERAPOBEC3G | |
| SCHEMBL7608782 | 0.78 | ADRB3 (0.75) | ADRB3ADRB1ADRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1230210-A1 | AMINOALCOHOL DERIVATIVES USEFUL FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2002-08-14 | — | — | EP | disclosed |
| WO-2001036375-A1 | AMINOALCOHOL DERIVATIVES USEFUL FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2001-05-25 | — | — | WO | disclosed |